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Pretreatment of rats with low doses of Cd produces adaptive tolerance to a subsequent high
dose of Cd-induced lethality, thus shifting the dose-response curve to the right. Cd pretreatment
of animals also protects against the hepatotoxicity produced by high doses of Cd. This protection
is attributable to the 10- to 50-fold induction of hepatic metallothionein (MT) by Cd pretreatment.
As a result hepatic subcellular distribution of Cd is significantly altered, with more Cd bound to
MT in the cytosol and a concomitant reduction of Cd in other critical organelles. In addition MT-
transgenic animals are more resistant, whereas MT-null mice are more sensitive than controls to
Cd-induced lethality and hepatotoxicity. This further demonstrates that MT is important in Cd
detoxication. Induction of hepatic MT by zinc also protects mice from carbon tetrachloride (CCI4)-
induced liver injury, with more 14C-CCI4 bound to MT in the cytosol. MT-null mice are more
sensitive to CCI4-induced hepatotoxicity, which supports the hypothesis that induction of MT also
plays a protective role for nonmetallic chemicals. These results indicate that MT is a part of
cellular adaptive mechanisms affecting the magnitude and progression of toxic insults from
metals such as Cd as well as from organic chemicals such as CCI4. - Environ Health Perspect
106(Suppl 1):297-300 (1998). http.//ehpnetl.niehs.nih.gov/docs/1998/Suppl-1/297-300klaassen/
abstract.html
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Introduction
Metallothionein (MT) is a low-molecular-
weight protein ubiquitous in the animal
kingdom (1). MT has an unusual amino
acid composition in that it has no aromatic
amino acids and one-third ofits residues are
cysteines. These cysteine residues bind and
store metal ions (2). The MT multigene
family is composed ofat least four isoforms.
MT-I and -II exist in all tissues, are regu-
lated in a coordinate fashion, and appear
functionally equivalent (1-3). Other mem-
bers ofthe MT gene family, however, show
different patterns ofexpression: MT-III is
found mainly in brain (4) and MT-IV in
stratified squamous epithelium (5). MT-Ill
and -IV are regulated very differently than
MT-I and -II and their significance is not
yet understood.
MT-I and -II can be induced easily by
heavy metals, hormones, inflammation,
acute stress, and many chemicals (1).
In essence induction of MT has been
proposed as an important adaptive mecha-
nism in response to environmental stim-
uli. Induction of MT protects against
metal toxicity (6), acts as a free radical
scavenger protecting against oxidative
damage (7), and protects against toxicity
of alkylating anticancer drugs and other
electrophiles (8).
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In this paper we demonstrate that
induction of MT is an important cellular
adaptive mechanism protecting against the
toxicity produced by metals such as Cd as
well as by organic chemicals such as carbon
tetrachloride (CC14).
InductionofMetallothionein
Protects againstCadmiumToxicity
Cd is an environmental pollutant that is
toxic to a number oftissues, including liver,
kidney, lung, bone, reproductive organs,
and the immune system (6). However, fol-
lowing low doses ofCd exposure, animals
become tolerant to a subsequent lethal dose
ofCd (9-13).
There have been several hypotheses
proposed to explain Cd-induced tolerance.
Originally it was hypothesized that Cd pre-
treatment alters the organ distribution of
Cd, with more Cd distributing to the liver
and less to the kidney. However no major
differences in the distribution ofCd to vari-
ous organs have been observed between
control and Cd-pretreated animals (12). It
was also hypothesized that tolerance to Cd-
induced lethality is attributable to increased
biliary excretion of Cd, which has not
turned out to be true either. Pretreatment
ofanimals with Cd or Zn actuallydecreased
or prevented the biliary excretion of
Cd (14,15).
Why do animals die from acute Cd
toxicity? It was originally thought that ani-
mals died from Cd-induced cardiotoxicity
or nephrotoxicity. However we know now
that this is not true. In fact we showed that
animals exposed to acute high doses ofCd
probably die from liver injury (16). The
liver accumulates substantial amounts of
Cd after both acute and chronic exposure
(6,17). Cd produces dose-dependent liver
injury in laboratory animals within 10 hr
after iv administration (16-19), with con-
gestion, apoptosis, necrosis, and peliosis as
major features ofinjury (16-20). The Cd-
induced liver injury is so severe that hepatic
failure is believed to be responsible for acute
Cd lethality (12,16,18).
Tolerance to acute Cd toxicity is appar-
ently attributable to MT protection
against Cd-induced acute hepatotoxicity
(10,12,13). Indeed, after treatment of
animals with a low dose of Cd, the liver
injury caused by a subsequent toxic dose of
Cd is markedly reduced (Figure 1). T-he
hepatoprotection is not attributable to a
decreased accumulation of Cd in the liver
(12). However, the subcellular distribution
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Figure 1. The protective effect of CdCI2 pretreatment
(2.0 mg/kg Cd sc for 24 hr) against the hepatotoxic
effects of the subsequent high doses of Cd challenge
(2.0-5.0 mg/kg Cd iv for 10 hr). Liver injury was mea-
sured by plasma aspartate AST. The 5.0 mg/kg dose
was not used in control rats as preliminary studies
indicate a high rate of mortality in this group. Values
represent mean ±SE of 4 to 6 rats. *Significantly differ-
ent from controls at p< 0.05. Abbreviation: AST,
aminotransferase activity. Reproduced from Goering
and Klaassen (12); with permission ofAcademic Press.
of Cd is dramatically altered, with more
Cd distributing to the cytosol and a signifi-
cant reduction of Cd in critical organelles
such as nucleus, mitochondria, and micro-
somes (Figure 2). Chromatography ofthe
cytosolic fraction indicates that most ofthe
Cd in Cd-pretreated animals is associated
with MT (Figure 3). Thus the protective
role ofMT in Cd tolerance to hepatic injury
is proposed.
Newborn animals have high concentra-
tions of MT in their livers; thus they are
resistant to Cd-induced lethality and hepato-
toxicity. For example Cd treatment (4.0
mg/kg) produced a 20-fold increase in serum
alanine aminotransferase activity in adult
rats, but in newborns (10-day-old rats) 6 mg
Cd/kg did not produce liver injury (21).
Recently we demonstrated that MT-I
transgenic mice, which have a 10-fold
higher concentration ofMT in their liver
than control mice (22), are resistant to Cd-
induced lethality and hepatotoxicity, as evi-
denced by >90% lower activities of serum
alanine aminotransferase and sorbitol dehy-
drogenase (Figure 4). In contrast MT-null
mice have an increased susceptibility to
Cd-induced lethality and hepatotoxicity
(23-25), and liver injury is more severe in
MT-null mice than in corresponding con-
trols (Figure 5). Furthermore Zn pretreat-
ment, which increases hepatic MT 20-fold
in control but not in MT-null mice, pro-
tects against Cd-induced hepatotoxicity in
control but not in MT-null mice (Figure 5),
thus supporting our earlier observation that
Figure 2. Hepatic subcellular distribution of 109CdCI2 2 hr
after challenge (3.5 mg/kg Cd iv) following saline or Cd
(2.0 mg/kg sc for 24 hr) pretreatment. The cellular pellets
were defined as Nuc (600 x g, 10 min), Mit (10,000 xg,
10 min), Mic (l100,OOOxg, 60 min), and Cyt (100,OOOxg
supernatant). Values represent mean±SE of six rats.
*Significantly different from controls at p<0.05.
Abbreviations: Cyt, cytosol; Mic, microsomes; Mit, mito-
chondria; Nuc, nuclei. Reproduced from Goering and
Klaassen (10), with permission ofAcademic Press.
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Figure 3. Representative gel-filtration elution profiles
of 109CdC12 in the hepatic cytosols 2 hr after challenge
(3.5 mg/kg Cd iv) in control or Cd (2.0 mg/kg sc for 24
hr) pretreated rats. Radioactive Cd eluting with reten-
tion coefficients (Ve/Vo) of 1.0 to 1.5 and 1.75 to 2.25
are Cd bound to high-molecular-weight proteins and
MT, respectively. Reproduced from Goering and
Klaassen (11), with permission ofAcademic Press.
Zn-induced tolerance to Cd is attributable
to induction ofMT (26).
These data indicate that both constitu-
tive and inducible MT are responsible for
the detoxication ofCd. Pharmacodynamic
tolerance occurs via high-affinity sequestra-
tion ofthe metal within the cell. As a result
most ofthe Cd in cells is bound to MT in
the cytosol, with a concomitant reduction of
the Cd available to bind/damage critical
organelles (6). Using MT-null mice, we
find that intracellular MT also plays an
important protective role in chronic Cd
nephrotoxicity Liu et al., in preparation).
Binding ofmetal ions to MT also appears to
be the mechanism for the protection against
the toxicity ofother metals such as mercury,
Figure 4. Serum ALT and SDH activities in control and
MT-TG mice 24 hr after injection of a hepatotoxic dose
of CdCI2 (3.1 mg/kg Cd iv). Values represent the mean
± SE of 16 to 25 mice. *Significantly different from con-
trols at p<0.05. Abbreviations: ALT, alanine amino-
transferase; SDH, sorbitol dehydrogenase; MT-TG,
MT-transgenic mouse. Reproduced from Liu et al. (22),
with permission ofAcademic Press.
Saline
Cd
5000- Zn+Cd
= 4000-
CO 3000 *
E
CO)
1000
0
Control MTnull
Figure 5. SDH activities in control and MT-null mice
pretreated with saline or Zn (200 pmol/kg, scx2) and
subsequently challenged with a hepatotoxic dose of
CdCI2 (2.8 mg/kg Cd ip for 16 hr). Values are mean±SE
(n= 16-24). *Significantly different from control mice
at p<0.05. **Significant difference between CdCI2 and
Zn +CdCI2 groups at p<0.05. Reproduced from Liu et
al. (25), with permission ofWilliams & Wilkens.
silver, and cisplatin (27,28). Thus, induction
ofMT is an important adaptive mechanism
preventing metal toxicity in animals as well
as in humans.
Induction ofMetallothionein
as anAdaptiveMechanism
forNonmetallic Chemicals
MT has a high cysteine content (30%)
and thus may be similar to glutathione in
providing another nucleophilic sink in the
cell that can bind electrophiles. MT in the
liver is induced by CCl4 administration
(29), indicating a possible role for this pro-
tein to provide tolerance to CCl4 toxicity.
We demonstrated that induction ofMT by
Zn protects against CC14 hepatotoxicity
Environmental Health Perspectives * Vol 106, Supplement * February 1998
--- Control
-0-- Cd pretreated
10,000 -
a)
= 1000-
--X
E
1-100-
Cl)
10-I
= Control
- MT-TG
T
a,
CD
Ad .
N
a,
CD
E
va
CD,
10,000-
8000-
-Wm-
2000-
0 0- Cyt
I
SDH ALT
l,
298METALLOTHIONEIN INDUCTION AS AN ADAPTIVE MECHANISM
5000 -U- Control
-0-- Zn pretreated
4000 -
CD
D 3000-
E 2000-
CD)
1000-
0
0.25 0.5 1 1.75
CCI4, mi/kg
Figure 6. The protective effect of Zn pretreatment
(ZnCI2 250 pmol/kg ip) against the hepatotoxicity of
carbon tetrachloride (0.3-1.75 ml/kg in corn oil, ip for
24 hr). Liver injury was measured by serum ALT. Values
represent mean ±SE of 4to 6 rats. *Significantly differ-
ent from controls at p<0.05. Reproduced from Goering
and Klaassen (30), with permission ofAcademic Press.
(Figure 6). Similar to the binding ofCd to
MT, more 14C from 14C-CC14 is bound to
MT in the MT-induced animals than in
controls (Figure 7), with a concomitant
reduction ofcovalent binding of 14C-CCl4
to cellular protein and lipid (30).
The potential role ofMT induction as
an adaptive mechanism decreasing CC4
toxicityis furthersupported byotherstudies.
First, 24-hr pretreatment with Zn increased
hepatic MT and protected against CC14
toxicity, while 2-hr Zn pretreatment prior
to the induction ofMT synthesis failed to
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Figure 7. Representative gel-filtration elution profiles
of 14C-C14 in the hepatic cytosols 90 min after adminis-
tration of 14C-C14 (25 pCi/kg ip) in control or Zn (250
pmol/kg, ip for 24 hr) pretreated rats. Radioactive 14C-
Cl4 eluting in fractions 15 to 25 and fractions 45 to 55
are 14C-C14 bound to high-molecular-weight proteins
and MT, respectively. Reproduced from Goering and
Klaassen (30), with permission ofAcademic Press.
offer protection (31). Second, mild Zn
deficiency interferes with MT synthesis
and thus decreases the efficacy of MT
induction by turpentine to protect against
CC14 toxicity (32). Third, recent studies
showed that MT-null mice are more sus-
ceptible than controls to CC14 hepatotoxic-
ity (33,34), indicating that MT functions
as an adaptive mechanism to decrease the
toxicity ofCCl4.
Evidence also suggests a role for MT in
protection aginst oxidative stress. MT can
serve as a sacrificial scavenger for hydroxyl
radicals in vitro (35) and protect against
free radical-induced DNA damage
(36-38). MT can also assume the func-
tion ofsuperoxide dismutase in yeast (39)
and protect against lipid peroxidation in
erythrocyte ghosts produced by xanthine
oxidase-derived superoxide anion and
hydrogen peroxide (40). Hepatocytes
from MT-null mice are more sensitive
than control cells to oxidative damage
produced by t-butylhydroperoxide and
paraquat (41,42). MT is induced by
oxidative stress-producing chemicals (43)
and thus may protect against oxidative
damage (7) and the toxicity ofalkylating
anticancer drugs (8).
Summary
MT, a cysteine-rich, metal-binding
protein, exists in most tissues and is easily
induced by many stimuli. Thus induction
of MT is an important cellular adaptive
mechanism in response to environmental
insults. MT plays an important role in Cd
tolerance and Cd-induced hepatotoxicity.
MT binds Cd in the hepatic cytosol and
renders it inert. MT may also function
similarly as glutathione in providing a
nucleophilic sink, and binding elec-
trophiles. MT may also act as a free radical
scavenger to protect against oxidative dam-
age as an adaptive mechanism in response
to nonmetallic toxicants. The functions of
MT warrant further investigation.
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